WithdrawnPhase 2NCT00003405
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rush University Medical Center
- Principal Investigator
- Philip D. Bonomi, MD, MDRush University Medical Center
- Intervention
- recombinant interferon alfa(biological)
- Eligibility
- 0-70 years · All sexes
- Timeline
- 1998 – 1999
Study locations (4)
- Cook County Hospital, Chicago, Illinois, United States
- Rush Cancer Institute, Chicago, Illinois, United States
- Angelo P. Creticos, M.D. Cancer Center, Chicago, Illinois, United States
- Rush-Riverside Cancer Center, Kankakee, Illinois, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003405 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.